FHH-F:CA:TSX-First Trust AlphaDEX U.S. Health Care Sector Index ETF (CAD)

ETF | Others |

Last Closing

CAD 29.57

Change

0.00 (0.00)%

Market Cap

CAD 0.01B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.07 (+0.26%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

-0.01 (-0.01%)

CAD 5.38B
XEQT:CA iShares Core Equity Portfolio

-0.14 (-0.43%)

CAD 5.22B
PHYS-U:CA Sprott Physical Gold Trust

-0.08 (-0.37%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.10 (-0.28%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

N/A

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.01 (+0.09%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.06 (-0.27%)

CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.02 (+0.04%)

CAD 2.68B

ETFs Containing FHH-F:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.77% 62% D 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.77% 62% D 59% D-
Trailing 12 Months  
Capital Gain 8.71% 30% F 35% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.71% 31% F 35% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -3.85% 7% C- 13% F
Dividend Return -3.85% 6% D- 10% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 6.25% 68% D+ 85% B
Risk Adjusted Return -61.55% 4% F 4% F
Market Capitalization 0.01B 27% F 12% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.